PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1174535
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1174535
Cell and Tissue Preservation Market size was valued at USD 3,108.5 Million in 2021, expanding at a CAGR of 13.8% from 2022 to 2028.
By destroying antigen-bearing cells, deep freezing and freeze-drying allograft tissue reduce immunogenicity. Cryopreservation is the controlled rate freezing procedure combined with the extraction of cellular water using glycerol and dimethyl sulfoxide. Some tissues and cells are preserved by this procedure.
The cell and tissue preservation market is increasing as a result of the growing usage of biobanks to understand the genetic roots of disease and develop a more personalized approach to healthcare. Additionally, pharmaceutical companies are increasing their investments in research and development to engage in drug discovery and development operations for incorporating numerous new and novel pharmaceuticals to treat conditions including diabetes, cancer, Parkinson's disease, Alzheimer's disease, and more. To reduce the risk of cross-contamination and transmission at reproductive facilities, businesses in the cell and tissue preservation market are becoming more conscious of these issues. There is a need for more information to confirm a link between coronavirus with reproductive organs, embryos, and gametes because the disease is so unique.
Further, the growing need for cryopreservation is another factor boosting market growth. By making it easier to keep therapeutic cells, tissues, and organs, cryopreservation has the potential to significantly advance a number of medical fields. However, it has been discovered that extracellular ice directly harms tissues by rupturing extracellular structures or crushing or puncturing cell membranes. Stakeholders are using cryopreservation techniques like the CPAs to lessen the scope of ice-related damage (cryoprotective agents). For cryopreservation, there is a need for mid-range automation. To address this demand, businesses in the cell and tissue preservation market are developing robots.
The Global Cell and Tissue Preservation Market are segmented on the basis of Type, Application, End User, and Region.
The market is split into two categories based on Type: cell preservation and tissue preservation. The cell preservation segment dominates the market. Growing demand for cell preservation such as plant cells, and microorganisms is mainly contributing to segment growth.
The market is segmented into four categories based on application: Therapeutics, research & development, drug discovery, and others. The therapeutics segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the demand for therapy-based diagnostics.
The market is segmented into three categories based on end-users: biobanks, hospitals, and others. The hospital segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the need for cell and tissue preservation for muscular disorders treatment.
The worldwide market for cell and tissue preservation is highly fragmented comprised of large and small-sized market players with a few large ones dominating the global market share. The companies in the market emphasize adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new Type launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in April 2022, Lonza expands the functionality of the Cocoon Platform by implementing magnetic cell selection for cell therapy division.
The scope of this report covers the market by its major segments, which include as follows: